Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/70199
Title: | Constituents of huberantha jenkinsii and their biological activities |
Authors: | Htoo Tint San Tanawat Chaowasku Wanwimon Mekboonsonglarp Ratchanee Rodsiri Boonchoo Sritularak Hathairat Buraphaka Waraporn Putalun Kittisak Likhitwitayawuid |
Authors: | Htoo Tint San Tanawat Chaowasku Wanwimon Mekboonsonglarp Ratchanee Rodsiri Boonchoo Sritularak Hathairat Buraphaka Waraporn Putalun Kittisak Likhitwitayawuid |
Keywords: | Biochemistry, Genetics and Molecular Biology;Chemistry;Pharmacology, Toxicology and Pharmaceutics |
Issue Date: | 1-Aug-2020 |
Abstract: | © 2020 by the authors. Licensee MDPI, Basel, Switzerland. The phytochemical investigation of Huberantha jenkinsii resulted in the isolation of two new and five known compounds. The new compounds were characterized as undescribed 8-oxoprotoberberine alkaloids and named huberanthines A and B, whereas the known compounds were identified as allantoin, oxylopinine, N-trans-feruloyl tyramine, N-trans-p-coumaroyl tyramine, and mangiferin. The structure determination was accomplished by spectroscopic methods. To evaluate therapeutic potential in diabetes and Parkinson’s disease, the isolates were subjected to assays for their α-glucosidase inhibitory activity, cellular glucose uptake stimulatory activity, and protective activity against neurotoxicity induced by 6-hydroxydopamine (6-OHDA). The results suggested that mangiferin was the most promising lead compound, demonstrating significant activity in all the test systems. |
URI: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089044822&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70199 |
ISSN: | 14203049 |
Appears in Collections: | CMUL: Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.